Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Spinocerebellar ataxia type 2 presenting as familial levodopa-responsive parkinsonism.

Literature DB >> 11761482

Spinocerebellar ataxia type 2 presenting as familial levodopa-responsive parkinsonism.

D E Shan¹, B W Soong, C M Sun, S J Lee, K K Liao, R S Liu.

Abstract

A genetic analysis identified 2 patients, approximately one-tenth of our patients with familial parkinsonism, who had expanded trinucleotide repeats in SCA2 genes. The reduction of 18F-dopa distribution in both the putamen and caudate nuclei confirmed that the nigrostriatal dopaminergic system was involved in parkinsonian patients with SCA2 mutation.

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2001 PMID： 11761482 DOI： 10.1002/ana.10055

Source DB: PubMed Journal: Ann Neurol ISSN： 0364-5134 Impact factor: 10.422

Keyword Cloud
Cited

20 in total

1. Magnetic resonance imaging in spinocerebellar ataxias.

Authors: Susanne Döhlinger; Till-Karsten Hauser; Johannes Borkert; Andreas R Luft; Jörg B Schulz
Journal: Cerebellum Date: 2008 Impact factor: 3.847

2. Lisuride reduces involuntary periodic leg movements in spinocerebellar ataxia type 2 patients.

Authors: Luis Velázquez-Pérez; Roberto Rodríguez-Labrada; Lázaro Álvarez-González; Raúl Aguilera-Rodríguez; Mario Álvarez Sánchez; Nalia Canales-Ochoa; Lourdes Galicia Polo; Reyes Haro-Valencia; Jacqueline Medrano-Montero; Yaimeé Vázquez-Mojena; Arnoy Peña-Acosta; Annelié Estupiñán-Rodríguez; Noemí Rodríguez Pupo
Journal: Cerebellum Date: 2012-12 Impact factor: 3.847

Review 3. Current concepts in the treatment of hereditary ataxias.

Authors: Pedro Braga Neto; José Luiz Pedroso; Sheng-Han Kuo; C França Marcondes Junior; Hélio Afonso Ghizoni Teive; Orlando Graziani Povoas Barsottini
Journal: Arq Neuropsiquiatr Date: 2016-03 Impact factor: 1.420

4. Psychotic-affective symptoms and multiple system atrophy expand phenotypes of spinocerebellar ataxia type 2.

Authors: Kai-Hsiang Chen; Chin-Hsien Lin; Ruey-Meei Wu
Journal: BMJ Case Rep Date: 2012-03-20

5. Spinocerebellar ataxia type 2 is associated with Parkinsonism and Lewy body pathology.

Authors: Masaki Takao; Masahiro Aoyama; Kinya Ishikawa; Yoshio Sakiyama; Harumi Yomono; Yuko Saito; Hiroshi Kurisaki; Ban Mihara; Shigeo Murayama
Journal: BMJ Case Rep Date: 2011-04-01

6. Topography of cerebral monoamine transporter availability in families with SCA2 mutations: a voxel-wise [123I]beta-CIT SPECT analysis.

Authors: Christoph Scherfler; Sylvia M Boesch; Eveline Donnemiller; Klaus Seppi; Helga Weirich-Schwaiger; Georg Goebel; Irene Virgolini; Gregor K Wenning; Werner Poewe
Journal: Eur J Nucl Med Mol Imaging Date: 2006-05-13 Impact factor: 9.236

Spinocerebellar ataxia type 2 presenting as familial levodopa-responsive parkinsonism.

1. Magnetic resonance imaging in spinocerebellar ataxias.

2. Lisuride reduces involuntary periodic leg movements in spinocerebellar ataxia type 2 patients.

Review 3. Current concepts in the treatment of hereditary ataxias.

4. Psychotic-affective symptoms and multiple system atrophy expand phenotypes of spinocerebellar ataxia type 2.

5. Spinocerebellar ataxia type 2 is associated with Parkinsonism and Lewy body pathology.

6. Topography of cerebral monoamine transporter availability in families with SCA2 mutations: a voxel-wise [123I]beta-CIT SPECT analysis.

7. Parkin is an E3 ubiquitin-ligase for normal and mutant ataxin-2 and prevents ataxin-2-induced cell death.

8. Transcranial sonography in spinocerebellar ataxia type 2.

Review 9. A pathogenetic classification of hereditary ataxias: is the time ripe?

10. Preclinical and clinical neural network changes in SCA2 parkinsonism.